Medicine and Dentistry
Patient
100%
Cord Blood Stem Cell Transplantation
60%
Inpatient
48%
Transplantation
38%
Acute Myeloid Leukemia
37%
Acute Lymphoblastic Leukemia
37%
Spontaneous Remission
31%
Hematopoietic Cell
30%
Cell Transplantation
30%
Hazard Ratio
27%
Minimal Residual Disease
22%
Donor
22%
Stomach Cancer
21%
Gene
21%
Surgery
21%
Kidney Development
21%
Peripheral Blood Stem Cell
21%
HLA-DRB1
21%
Conditioning
21%
Allogeneic Hematopoietic Stem Cell Transplantation
21%
Overall Survival
20%
Adult
19%
Mortality
19%
Peripheral Blood Stem Cell Transplantation
17%
Survival Rate
15%
Bone Marrow Transplantation
14%
HLA-A
14%
Relapse
13%
Recurrence Risk
13%
Diseases
12%
Coloboma
12%
Syndrome
12%
Therapeutic Procedure
11%
Age
10%
Chemotherapy
10%
Prognostic Factor
10%
Chemotherapeutic Agent
10%
Drug
10%
Prognosis
10%
Analysis
9%
Progression Free Survival
9%
Leukemia
8%
Acute Leukemia
8%
Cord Blood
8%
Survival
8%
Association
8%
Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide Like
7%
Bone Marrow
7%
Chronic Graft Versus Host Disease
6%
Graft Versus Host Reaction
6%
Biochemistry, Genetics and Molecular Biology
Mutation
44%
Cell Transplantation
29%
APOBEC
28%
Overall Survival
24%
Myeloid
22%
Cord Blood Stem Cell Transplantation
21%
Enhancer Region
21%
DNA
21%
PAX2
21%
Conditioning
17%
Allogeneic Hematopoietic Stem Cell Transplantation
17%
Gene Expression
17%
Cis-Regulatory Element
17%
Nested Gene
14%
Cell Cycle M Phase
14%
Time
13%
Relapse
12%
RNA
12%
Survival Rate
10%
Philadelphia Chromosome
10%
Cytosine
10%
Multivariate Analysis
10%
Cytosine Deaminase
8%
Transcription
8%
Promoter Region
8%
Bone
7%
RNA Sequence
7%
Age
5%
Mortality
5%
Real-Time Polymerase Chain Reaction
5%
Apolipoprotein B
5%
Loss of Function Mutation
5%
Messenger RNA
5%
Lysozyme
5%
Clonal Evolution
5%
DNA Repair
5%
Electric Potential
5%
Genome Instability
5%
Clone
5%
Immunology and Microbiology
Cells
43%
Cell Transplantation
33%
Bone Marrow
28%
Mutation
28%
Human Leukocyte Antigen
21%
HLA DRB1 Antigen
21%
Overall Survival
20%
Transplantation
17%
Cell Cycle M Phase
14%
Cord Blood Stem Cell Transplantation
14%
Acute Graft Versus Host Disease
13%
Myeloid
12%
Human Immunodeficiency Virus
11%
Hemocyte
10%
Survival Rate
10%
Philadelphia 1 Chromosome
10%
Age
9%
Mortality
9%
Time
8%
Myeloma Cell
7%
RNA Sequence
7%
Allogeneic Hematopoietic Stem Cell Transplantation
5%
Allogeneic Stem Cell Transplantation
5%
Contrast
5%